Logo image of PRPL

PURPLE INNOVATION INC (PRPL) Stock Fundamental Analysis

NASDAQ:PRPL - Nasdaq - US74640Y1064 - Common Stock - Currency: USD

0.824  +0.02 (+3%)

After market: 0.8077 -0.02 (-1.98%)

Fundamental Rating

1

Overall PRPL gets a fundamental rating of 1 out of 10. We evaluated PRPL against 63 industry peers in the Household Durables industry. PRPL has a bad profitability rating. Also its financial health evaluation is rather negative. PRPL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PRPL has reported negative net income.
PRPL had a negative operating cash flow in the past year.
PRPL had negative earnings in 4 of the past 5 years.
PRPL had negative operating cash flow in 4 of the past 5 years.
PRPL Yearly Net Income VS EBIT VS OCF VS FCFPRPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

PRPL's Return On Assets of -27.71% is on the low side compared to the rest of the industry. PRPL is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
ROA -27.71%
ROE N/A
ROIC N/A
ROA(3y)-27.81%
ROA(5y)-25.1%
ROE(3y)-213.59%
ROE(5y)-198.11%
ROIC(3y)N/A
ROIC(5y)N/A
PRPL Yearly ROA, ROE, ROICPRPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

PRPL has a better Gross Margin (40.63%) than 77.78% of its industry peers.
PRPL's Gross Margin has declined in the last couple of years.
PRPL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y-1.8%
PRPL Yearly Profit, Operating, Gross MarginsPRPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

PRPL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PRPL has more shares outstanding
Compared to 5 years ago, PRPL has more shares outstanding
PRPL has a worse debt/assets ratio than last year.
PRPL Yearly Shares OutstandingPRPL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PRPL Yearly Total Debt VS Total AssetsPRPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

PRPL has an Altman-Z score of -1.42. This is a bad value and indicates that PRPL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.42, PRPL is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.42
ROIC/WACCN/A
WACC8.46%
PRPL Yearly LT Debt VS Equity VS FCFPRPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.49 indicates that PRPL should not have too much problems paying its short term obligations.
PRPL has a Current ratio of 1.49. This is in the lower half of the industry: PRPL underperforms 76.19% of its industry peers.
PRPL has a Quick Ratio of 1.49. This is a bad value and indicates that PRPL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PRPL (0.77) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.77
PRPL Yearly Current Assets VS Current LiabilitesPRPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.08% over the past year.
The Revenue for PRPL has decreased by -13.19% in the past year. This is quite bad
Measured over the past years, PRPL shows a small growth in Revenue. The Revenue has been growing by 2.63% on average per year.
EPS 1Y (TTM)43.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)-13.19%
Revenue growth 3Y-12.42%
Revenue growth 5Y2.63%
Sales Q2Q%-12.61%

3.2 Future

Based on estimates for the next years, PRPL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.87% on average per year.
The Revenue is expected to grow by 4.61% on average over the next years.
EPS Next Y30.99%
EPS Next 2Y24.44%
EPS Next 3Y20.52%
EPS Next 5Y14.87%
Revenue Next Year-4.36%
Revenue Next 2Y2.87%
Revenue Next 3Y4.7%
Revenue Next 5Y4.61%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRPL Yearly Revenue VS EstimatesPRPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
PRPL Yearly EPS VS EstimatesPRPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRPL. In the last year negative earnings were reported.
Also next year PRPL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRPL Price Earnings VS Forward Price EarningsPRPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRPL Per share dataPRPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PRPL's earnings are expected to grow with 20.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.44%
EPS Next 3Y20.52%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRPL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURPLE INNOVATION INC

NASDAQ:PRPL (8/8/2025, 8:01:26 PM)

After market: 0.8077 -0.02 (-1.98%)

0.824

+0.02 (+3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners70.17%
Inst Owner Change0.42%
Ins Owners4.63%
Ins Owner Change11.35%
Market Cap89.33M
Analysts76.36
Price Target3.37 (308.98%)
Short Float %2.03%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.19%
Min EPS beat(2)-1.74%
Max EPS beat(2)20.12%
EPS beat(4)3
Avg EPS beat(4)22.47%
Min EPS beat(4)-1.74%
Max EPS beat(4)49.16%
EPS beat(8)4
Avg EPS beat(8)-64.93%
EPS beat(12)6
Avg EPS beat(12)-40.61%
EPS beat(16)7
Avg EPS beat(16)-42.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-3.25%
Min Revenue beat(4)-8.17%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-4.96%
Revenue beat(12)2
Avg Revenue beat(12)-3.97%
Revenue beat(16)4
Avg Revenue beat(16)-3.91%
PT rev (1m)30.26%
PT rev (3m)78.38%
EPS NQ rev (1m)-13.16%
EPS NQ rev (3m)-24.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.35%
Revenue NQ rev (1m)1.36%
Revenue NQ rev (3m)-2.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS4.21
BVpS-0.14
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.63%
FCFM N/A
ROA(3y)-27.81%
ROA(5y)-25.1%
ROE(3y)-213.59%
ROE(5y)-198.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y-1.8%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.01%
Cap/Sales 1.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.77
Altman-Z -1.42
F-Score5
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)100.05%
Cap/Depr(5y)279.63%
Cap/Sales(3y)3.72%
Cap/Sales(5y)5.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y30.99%
EPS Next 2Y24.44%
EPS Next 3Y20.52%
EPS Next 5Y14.87%
Revenue 1Y (TTM)-13.19%
Revenue growth 3Y-12.42%
Revenue growth 5Y2.63%
Sales Q2Q%-12.61%
Revenue Next Year-4.36%
Revenue Next 2Y2.87%
Revenue Next 3Y4.7%
Revenue Next 5Y4.61%
EBIT growth 1Y48.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.31%
EBIT Next 3Y29.91%
EBIT Next 5Y19.76%
FCF growth 1Y15.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.82%
OCF growth 3YN/A
OCF growth 5YN/A